DalsnaFinance › IPOs › Ascentage Pharma Group International › IPO
ASCENTAGE PHARMA GROUP INTERNATIONAL completed its initial public offering on NASDAQ on January 24, 2025, pricing at $17.25 a share.
| Ticker | AAPG |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 24, 2025 |
| Offering price | $17.25 |
| Shares offered | 7,325,000 |
| Total raised | $126M |
ASCENTAGE PHARMA GROUP INTERNATIONAL sold 7,325,000 shares at $17.25 each on NASDAQ. Multiplied out, that is $126.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $126 million total recorded for the deal.
Measured by money raised, ASCENTAGE PHARMA GROUP INTERNATIONAL was the 307th largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is the 228th largest.
January 2025 saw 17 completed IPOs in the site's data; by amount raised, ASCENTAGE PHARMA GROUP INTERNATIONAL was the 13th largest of the 17 deals with a recorded size.
Its $17.25 offer price was the 95th highest of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
ASCENTAGE PHARMA GROUP INTERNATIONAL — quote, profile and latest news →
Source: SEC EDGAR filings for ASCENTAGE PHARMA GROUP INTERNATIONAL. This page is general information, not investment advice.